2 assets in Familial Visceral Amyloidosis

Therapeutic assets addressing Familial Visceral Amyloidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aln-Ttrsc04 Familial Visceral Amyloidosis	Alnylam Pharmaceuticals	P1	CC (47)
Eplontersen Familial Visceral Amyloidosis	AstraZeneca	P1	CC (47)